FindTrial
Sign In

Clinical Trial of Thoracolaparoscopic Minimally Invasive Esophagectomy with Three-Field Lymphadenectomy for patients with Esophageal cancer

Clinical Trial of Thoracolaparoscopic Minimally Invasive Esophagectomy with Three-Field Lymphadenectomy for patients with Esophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16007957
Enrollment
Unknown
Registered
2016-02-20
Start date
2016-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

study group:thoracolaparoscopic minimally invasive esophagectomy with three-field lymphadenectomy
control group:thoracolaparoscopic minimally invasive esophagectomy with two-field lymphadenectomy

Sponsors

Chinese PLA Navy General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) esophageal squamous cell carcinoma identified via pathological examination; 2) male or female; 3) aged from 18 to 75 year-old; 4) resectable primary tumor(T1-4a, N0-1, M0).

Exclusion criteria

Exclusion criteria: 1) with malignancy tumor at other site; 2) with distant metastasis; 3) with severe cardiac or pulmonary disease, or other chronic disease that result in contraindication; 4) sever stomach disease; 5) history of radiation therapy or/and chemotherapy; 6) patient refusal.

Design outcomes

Primary

MeasureTime frame
number of lymph nodes dissected;—

Secondary

MeasureTime frame
operation duration;survival time;—

Countries

China

Contacts

Public ContactGong Taiqian
gongtq@hotmail.com+86 18600310218

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026